We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Alter drug structure—avert induced lupus

Elizabeth Rasche González
JAMA. 1981;246(15):1634. doi:10.1001/jama.1981.03320150006003.
Text Size: A A A
Published online


It is well known that some patients develop a syndrome resembling systemic lupus erythematosus in response to therapy with hydrazines or aromatic amines—notably with procainamide for arrhythmias, hydralazine for hypertension, and isoniazid for tuberculosis. New work suggests that minor molecular modifications of the offending agents might make it possible to use them without causing the lupus-like disease.

Most patients in whom drug-induced lupus develops are genetically slow acetylators, that is, in the course of metabolizing the drug in question, their livers add an acetyl group to the molecule at a relatively leisurely pace. With this finding in mind, Marcus A. Reidenberg, MD, professor of pharmacology and medicine and head, division of clinical pharmacology, Cornell University Medical College, and associates gave the acetylated version of procainamide—acecainide hydrochloride, also called N-acetylprocainamide—to 11 patients with ventricular arrhythmias and histories of procainamide lupus. In seven of these patients acecainide caused no recurrence of lupus;


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.